An Ethical Framework for Allocating Scarce Inpatient Medications for COVID-19 in the US

The authors of a viewpoint in JAMA offer an ethical framework for making decisions about distributing parenteral medications that are in short supply (e.g., remdesivir, monoclonal antibodies) to hospitalized COVID-19 patients. It’s worth a read.

https://jamanetwork.com/journals/jama/fullarticle/2766294